201 related articles for article (PubMed ID: 33902676)
1. Implications of cardiac markers in risk-stratification and management for COVID-19 patients.
Li P; Wu W; Zhang T; Wang Z; Li J; Zhu M; Liang Y; You W; Li K; Ding R; Huang B; Wu L; Duan W; Han Y; Li X; Tang X; Wang X; Shen H; Wang Q; Yan H; Xia X; Ji Y; Chen H
Crit Care; 2021 Apr; 25(1):158. PubMed ID: 33902676
[TBL] [Abstract][Full Text] [Related]
2. Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19.
Stefanini GG; Chiarito M; Ferrante G; Cannata F; Azzolini E; Viggiani G; De Marco A; Briani M; Bocciolone M; Bragato R; Corrada E; Gasparini GL; Marconi M; Monti L; Pagnotta PA; Panico C; Pini D; Regazzoli D; My I; Kallikourdis M; Ciccarelli M; Badalamenti S; Aghemo A; Reimers B; Condorelli G;
Heart; 2020 Oct; 106(19):1512-1518. PubMed ID: 32817312
[TBL] [Abstract][Full Text] [Related]
3. Association between cardiac troponin I and mortality in patients with COVID-19.
Salvatici M; Barbieri B; Cioffi SMG; Morenghi E; Leone FP; Maura F; Moriello G; Sandri MT
Biomarkers; 2020 Dec; 25(8):634-640. PubMed ID: 33003961
[TBL] [Abstract][Full Text] [Related]
4. Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review.
Li X; Pan X; Li Y; An N; Xing Y; Yang F; Tian L; Sun J; Gao Y; Shang H; Xing Y
Crit Care; 2020 Jul; 24(1):468. PubMed ID: 32723362
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of cardiac injury in COVID-19 patients with and without coronary artery disease.
Barman HA; Atici A; Sahin I; Alici G; Aktas Tekin E; Baycan ÖF; Ozturk F; Oflar E; Tugrul S; Yavuz MB; Celik FB; Oktay A; Vahaboglu H; Adas M; Turgut N; Okuyan E; Yildirmak MT; Gungor B
Coron Artery Dis; 2021 Aug; 32(5):359-366. PubMed ID: 32568741
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients.
Li C; Jiang J; Wang F; Zhou N; Veronese G; Moslehi JJ; Ammirati E; Wang DW
J Mol Cell Cardiol; 2020 Oct; 147():74-87. PubMed ID: 32827510
[TBL] [Abstract][Full Text] [Related]
7. The role of concomitant cardiovascular diseases and cardiac biomarkers for predicting mortality in critical COVID-19 patients.
Aladağ N; Atabey RD
Acta Cardiol; 2021 Apr; 76(2):132-139. PubMed ID: 32883169
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
[TBL] [Abstract][Full Text] [Related]
9. Clinical Course and Risk Factors of Disease Deterioration in Critically Ill Patients with COVID-19.
Qin W; Bai W; Liu K; Liu Y; Meng X; Zhang K; Zhang M
Hum Gene Ther; 2021 Mar; 32(5-6):310-315. PubMed ID: 33412996
[TBL] [Abstract][Full Text] [Related]
10. Impact and Determinants of High-Sensitivity Cardiac Troponin-T Concentration in Patients With COVID-19 Admitted to Critical Care.
Demir OM; Ryan M; Cirillo C; Desai N; Pericao A; Sinclair H; Stylianidis V; Victor K; Alaour B; Jones A; Pavlidis AN; Retter A; Carr-White G; Camporota L; Barrett N; Marber M; Perera D
Am J Cardiol; 2021 May; 147():129-136. PubMed ID: 33617816
[TBL] [Abstract][Full Text] [Related]
11. Association Between Average Plasma Potassium Levels and 30-day Mortality During Hospitalization in Patients with COVID-19 in Wuhan, China.
Liu S; Zhang L; Weng H; Yang F; Jin H; Fan F; Zheng X; Yang H; Li H; Zhang Y; Li J
Int J Med Sci; 2021; 18(3):736-743. PubMed ID: 33437208
[No Abstract] [Full Text] [Related]
12. CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study.
Lorè NI; De Lorenzo R; Rancoita PMV; Cugnata F; Agresti A; Benedetti F; Bianchi ME; Bonini C; Capobianco A; Conte C; Corti A; Furlan R; Mantegani P; Maugeri N; Sciorati C; Saliu F; Silvestri L; Tresoldi C; ; Ciceri F; Rovere-Querini P; Di Serio C; Cirillo DM; Manfredi AA
Mol Med; 2021 Oct; 27(1):129. PubMed ID: 34663207
[TBL] [Abstract][Full Text] [Related]
13. Possible role of higher serum level of myoglobin as predictor of worse prognosis in Sars-Cov 2 hospitalized patients. A monocentric retrospective study.
Rotondo C; Corrado A; Colia R; Maruotti N; Sciacca S; Lops L; Cici D; Mele A; Trotta A; Lacedonia D; Foschino Barbaro MP; Cantatore FP
Postgrad Med; 2021 Aug; 133(6):688-693. PubMed ID: 34176427
[TBL] [Abstract][Full Text] [Related]
14. Myocardial injury and COVID-19: Serum hs-cTnI level in risk stratification and the prediction of 30-day fatality in COVID-19 patients with no prior cardiovascular disease.
Cao J; Zheng Y; Luo Z; Mei Z; Yao Y; Liu Z; Liang C; Yang H; Song Y; Yu K; Gao Y; Zhu C; Huang Z; Qian J; Ge J
Theranostics; 2020; 10(21):9663-9673. PubMed ID: 32863952
[No Abstract] [Full Text] [Related]
15. Elevated α-hydroxybutyrate dehydrogenase as an independent prognostic factor for mortality in hospitalized patients with COVID-19.
Liu Z; Li J; Li M; Chen S; Gao R; Zeng G; Chen D; Wang S; Li Q; Hu D; Zeng W; Guo L; Wu X
ESC Heart Fail; 2021 Feb; 8(1):644-651. PubMed ID: 33336560
[TBL] [Abstract][Full Text] [Related]
16. Myocardial injury in severe and critical coronavirus disease 2019 patients.
Guo H; Shen Y; Wu N; Sun X
J Card Surg; 2021 Jan; 36(1):82-88. PubMed ID: 33135188
[TBL] [Abstract][Full Text] [Related]
17. Association of cardiac injury with hypertension in hospitalized patients with COVID-19 in China.
Zeng X; Rathinasabapathy A; Liu D; Zha L; Liu X; Tang Y; Li F; Lin W; Yu Z; Chen H
Sci Rep; 2021 Nov; 11(1):22389. PubMed ID: 34789776
[TBL] [Abstract][Full Text] [Related]
18. [Risks factors for death among COVID-19 patients combined with hypertension, coronary heart disease or diabetes].
Yang H; Yang LC; Zhang RT; Ling YP; Ge QG
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 52(3):420-424. PubMed ID: 32541972
[TBL] [Abstract][Full Text] [Related]
19. [Cardiac presentations in severe and critical coronavirus disease 2019].
Tong Y; Xie Z; Li Y; Lyu M; Deng X; Zhang F; Lei C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):229-232. PubMed ID: 33729145
[TBL] [Abstract][Full Text] [Related]
20. A nomogramic model based on clinical and laboratory parameters at admission for predicting the survival of COVID-19 patients.
Ma X; Wang H; Huang J; Geng Y; Jiang S; Zhou Q; Chen X; Hu H; Li W; Zhou C; Gao X; Peng N; Deng Y
BMC Infect Dis; 2020 Nov; 20(1):899. PubMed ID: 33256643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
